Cobertura EASD 2025 - Semaglutida Oral no Soul: Maior benefício CV com HBA1C  8% - Dhiãnah Santini e Luciano Albuquerque episode artwork

EPISODE · Dec 5, 2025 · 2 MIN

Cobertura EASD 2025 - Semaglutida Oral no Soul: Maior benefício CV com HBA1C 8% - Dhiãnah Santini e Luciano Albuquerque

from Podcast SBD - Profissional

#SemaglutidaOra #HBA1C #Diabetes #EASD2025

Episode metadata supplied by the publisher feed · Published Dec 5, 2025

Embed this episode

Ready to play

Cobertura EASD 2025 - Semaglutida Oral no Soul: Maior benefício CV com HBA1C 8% - Dhiãnah Santini e Luciano Albuquerque

0:00 2:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Podcast SBD - Profissional?

This episode is 2 minutes long.

When was this Podcast SBD - Profissional episode published?

This episode was published on December 5, 2025.

Can I download this Podcast SBD - Profissional episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!